<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40035292</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-3841</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of food science</Title><ISOAbbreviation>J Food Sci</ISOAbbreviation></Journal><ArticleTitle>The effects of low FODMAP diet on gut microbiota regulation: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e70072</StartPage><MedlinePgn>e70072</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1750-3841.70072</ELocationID><Abstract><AbstractText>This systematic review and meta-analysis aimed to evaluate the effects of a low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet on gut microbiota regulation. A comprehensive literature search was conducted in PubMed, Cochrane Library, Web of Science, Embase, CNKI (China National Knowledge Infrastructure), and Wanfang Data databases. Randomized controlled trials (RCTs) comparing low FODMAP diets with normal diets were included. The primary outcome was the effect on intestinal flora. The standardized mean difference (SMD) with 95% confidence intervals (CI) was calculated using a random-effects model. Heterogeneity was assessed using the I<sup>2</sup> statistic, and publication bias was evaluated using funnel plots and Egger's test. Ten RCTs involving 590 participants were included in the analysis. The low FODMAP diet showed a significant positive effect on intestinal flora compared to normal diets (SMD&#xa0;=&#xa0;0.33, 95% CI [0.01, 0.64], p&#xa0;=&#xa0;0.003). Substantial heterogeneity was observed (I<sup>2</sup>&#xa0;=&#xa0;67.5%). Subgroup analysis of irritable bowel syndrome (IBS) patients revealed no significant difference between low FODMAP and normal diets (SMD&#xa0;=&#xa0;0.08, 95% CI [-0.17, 0.32], p&#xa0;=&#xa0;0.306), with low heterogeneity (I<sup>2</sup>&#xa0;=&#xa0;17.0%). No significant publication bias was detected (Egger's test, p&#xa0;=&#xa0;0.328). This meta-analysis suggests that a low FODMAP diet may have a positive effect on gut microbiota regulation. However, the effect appears to be less pronounced in IBS patients. Further high-quality studies are needed to confirm these findings and explore the long-term impact of low FODMAP diets on gut health across various gastrointestinal disorders.</AbstractText><CopyrightInformation>&#xa9; 2025 Institute of Food Technologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Panpan</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0003-4811-9369</Identifier><AffiliationInfo><Affiliation>Department of Biological and Food Engineering, Lyuliang University, Lyuliang City, Shanxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biological and Food Engineering, Lyuliang University, Lyuliang City, Shanxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Fenglan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biological and Food Engineering, Lyuliang University, Lyuliang City, Shanxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaojing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biological and Food Engineering, Lyuliang University, Lyuliang City, Shanxi Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Lyuliang Science and Technology Plan Project (2023NYYF16)</Agency><Country/></Grant><Grant><Agency>Shanxi Province Higher Education Science and Technology Innovation Project (2019L0984)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Food Sci</MedlineTA><NlmUniqueID>0014052</NlmUniqueID><ISSNLinking>0022-1147</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009844">Oligosaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004187">Disaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009005">Monosaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C024617">polyol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011108">Polymers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009844" MajorTopicYN="N">Oligosaccharides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004187" MajorTopicYN="N">Disaccharides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009005" MajorTopicYN="N">Monosaccharides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011108" MajorTopicYN="N">Polymers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005285" MajorTopicYN="N">Fermentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050528" MajorTopicYN="Y">Diet, Carbohydrate-Restricted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092622" MajorTopicYN="N">FODMAP Diet</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FODMAP</Keyword><Keyword MajorTopicYN="N">gastrointestinal disorders</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">meta&#x2010;analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>4</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>4</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40035292</ArticleId><ArticleId IdType="doi">10.1111/1750-3841.70072</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Barrett, J. S., &amp; Gibson, P. R. (2012). Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therapetic Advances in Gastroenterolgoy, 5(4), 261&#x2013;268. https://doi.org/10.1177/1756283x11436241</Citation></Reference><Reference><Citation>Bascu&#xf1;&#xe1;n, K. A., Elli, L., Pellegrini, N., Scricciolo, A., Lombardo, V., Doneda, L., Vecchi, M., Scarpa, C., Araya, M., &amp; Roncoroni, L. (2019). Impact of FODMAP Content Restrictions on the quality of diet for patients with celiac disease on a gluten&#x2010;free diet. Nutrients, 11(9), 2220. https://doi.org/10.3390/nu11092220</Citation></Reference><Reference><Citation>Bennet, S. M. P., B&#xf6;hn, L., St&#xf6;rsrud, S., Liljebo, T., Collin, L., Lindfors, P., T&#xf6;rnblom, H., &#xd6;hman, L., &amp; Simr&#xe9;n, M. (2018). Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut, 67(5), 872&#x2013;881. https://doi.org/10.1136/gutjnl&#x2010;2016&#x2010;313128</Citation></Reference><Reference><Citation>Biesiekierski, J. R., Newnham, E. D., Irving, P. M., Barrett, J. S., Haines, M., Doecke, J. D., Shepherd, S. J., Muir, J. G., &amp; Gibson, P. R. (2011). Gluten causes gastrointestinal symptoms in subjects without celiac disease: A double&#x2010;blind randomized placebo&#x2010;controlled trial. American Journal of Gastroenterology, 106(3), 508&#x2013;514. https://doi.org/10.1038/ajg.2010.487</Citation></Reference><Reference><Citation>Chumpitazi, B. P., Cope, J. L., Hollister, E. B., Tsai, C. M., McMeans, A. R., Luna, R. A., Versalovic, J., &amp; Shulman, R. J. (2015). Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology &amp; Therapeutics, 42(4), 418&#x2013;427. https://doi.org/10.1111/apt.13286</Citation></Reference><Reference><Citation>Defrees, D. N., &amp; Bailey, J. (2017). Irritable bowel syndrome: Epidemiology, pathophysiology, diagnosis, and treatment. Primary Care, 44(4), 655&#x2013;671. https://doi.org/10.1016/j.pop.2017.07.009</Citation></Reference><Reference><Citation>De Preter, V. L., Verbeke, K., Vermeire, S., &amp; Rutgeerts, P. (2008). Alteration of fecal bifidobacterium species composition in patients with Crohn's disease on exclusive enteral nutrition. Digestive Diseases and Sciences, 53(1), 222&#x2013;231. https://doi.org/10.1007/s10620&#x2010;007&#x2010;0054&#x2010;5</Citation></Reference><Reference><Citation>Gibson, P. R., &amp; Shepherd, S. J. (2010). Evidence&#x2010;based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of Gastroenterology and Hepatology, 25(2), 252&#x2013;258. https://doi.org/10.1111/j.1440&#x2010;1746.2009.06149.x</Citation></Reference><Reference><Citation>Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., &amp; Muir, J. G. (2014). A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology, 146(1), 67&#x2013;75.e5. https://doi.org/10.1053/j.gastro.2013.09.046</Citation></Reference><Reference><Citation>Herfindal, A. M., Van Megen, F., Gilde, M. K. O., Valeur, J., Rudi, K., Skodje, G. I., Lundin, K. E. A., Henriksen, C., &amp; B&#xf8;hn, S. K. (2023). Effects of a low FODMAP diet on gut microbiota in individuals with treated coeliac disease having persistent gastrointestinal symptoms&#x2014;A randomised c1ontrolled trial. British Journal of Nutrition, 130(12), 2061&#x2013;2075. https://doi.org/10.1017/S0007114523001253</Citation></Reference><Reference><Citation>Mcintosh, K., Reed, D. E., Schneider, T., Dang, F., Keshteli, A. H., De Palma, G., Madsen, K., Bercik, P., &amp; Vanner, S. (2017). FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial. Gut, 66(7), 1241&#x2013;1251. https://doi.org/10.1136/gutjnl&#x2010;2015&#x2010;311339</Citation></Reference><Reference><Citation>Mckenzie, Y. A., Bowyer, R. K., Leach, H., Gulia, P., Horobin, J., O'Sullivan, N. A., Pettitt, C., Reeves, L. B., Seamark, L., Williams, M., Thompson, J., &amp; Lomer, M. C. E. (2016). British Dietetic Association systematic review and evidence&#x2010;based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics, 29(5), 549&#x2013;575. https://doi.org/10.1111/jhn.12385</Citation></Reference><Reference><Citation>Monash University. FODMAPs: What are they? Updated 2021. https://www.monashfodmap.com/i&#x2010;have&#x2010;ibs/what&#x2010;are&#x2010;fodmaps/</Citation></Reference><Reference><Citation>Naseri, K., Dabiri, H., Rostami&#x2010;Nejad, M., Yadegar, A., Houri, H., Olfatifar, M., Sadeghi, A., Saadati, S., Ciacci, C., Iovino, P., &amp; Zali, M. R. (2021). Influence of low FODMAP&#x2010;gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterology, 21(1), 292. https://doi.org/10.1186/s12876&#x2010;021&#x2010;01868&#x2010;5</Citation></Reference><Reference><Citation>Niewiem, M., &amp; Grzybowska&#x2010;Chlebowczyk, U. (2022). Intestinal barrier permeability in allergic diseases. Nutrients, 14(9), 1893. https://doi.org/10.3390/nu14091893</Citation></Reference><Reference><Citation>Nordin, E., Hellstr&#xf6;m, P. M., Dicksved, J., Pelve, E., Landberg, R., &amp; Brunius, C. (2023). Effects of FODMAPs and gluten on gut microbiota and their association with the metabolome in irritable bowel syndrome: A double&#x2010;blind, randomized, cross&#x2010;over intervention study. Nutrients, 15(13), 3045. https://doi.org/10.3390/nu15133045</Citation></Reference><Reference><Citation>Pedersen, N., Ankersen, D. V., Felding, M., Wachmann, H., V&#xe9;gh, Z., Molzen, L., Burisch, J., Andersen, J. R., &amp; Munkholm, P. (2017). Low&#x2010;FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World Journal of Gastroenterology, 23(18), 3356&#x2013;3366. https://doi.org/10.3748/wjg.v23.i18.3356</Citation></Reference><Reference><Citation>Quigley, E. M. (2013). Gut bacteria in health and disease. Gastroenterology &amp; Hepatology (N Y), 9(9), 560&#x2013;569.</Citation></Reference><Reference><Citation>Roncoroni, L., Bascu&#xf1;&#xe1;n, K. A., Doneda, L., Scricciolo, A., Lombardo, V., Branchi, F., Ferretti, F., Dell'osso, B., Montanari, V., Bardella, M. T., &amp; Elli, L. (2018). A Low FODMAP gluten&#x2010;free diet improves functional gastrointestinal disorders and overall mental health of celiac disease patients: A randomized controlled trial. Nutrients, 10(8), 1023. https://doi.org/10.3390/nu10081023</Citation></Reference><Reference><Citation>Staudacher, H. M., Lomer, M. C. E., Anderson, J. L., Barrett, J. S., Muir, J. G., Irving, P. M., &amp; Whelan, K. (2012). Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. Journal of Nutrition, 142(8), 1510&#x2013;1518. https://doi.org/10.3945/jn.112.159285</Citation></Reference><Reference><Citation>Staudacher, H. M., &amp; Whelan, K. (2017). The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS. Gut, 66(9), 1517&#x2013;1527. https://doi.org/10.1136/gutjnl&#x2010;2017&#x2010;313752</Citation></Reference><Reference><Citation>Sun, Q., Jia, Q., Song, L., &amp; Duan, L. (2019). Alterations in fecal short&#x2010;chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta&#x2010;analysis. Medicine, 98(7), e14513. https://doi.org/10.1097/MD.0000000000014513</Citation></Reference><Reference><Citation>Valitutti, F., &amp; Fasano, A. (2019). Breaking down barriers: How understanding celiac disease pathogenesis informed the development of novel treatments. Digestive Disease and Sciences, 64(7), 1748&#x2013;1758. https://doi.org/10.1007/s10620&#x2010;019&#x2010;05646&#x2010;y</Citation></Reference><Reference><Citation>Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., Louis, P., Mcintosh, F., Johnstone, A. M., Lobley, G. E., Parkhill, J., &amp; Flint, H. J. (2011). Dominant and diet&#x2010;responsive groups of bacteria within the human colonic microbiota. The ISME Journal, 5(2), 220&#x2013;230. https://doi.org/10.1038/ismej.2010.118</Citation></Reference><Reference><Citation>Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., Dugar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.&#x2010;M., Wu, Y., Schauer, P., Smith, J. D., Allayee, H., Tang, W. H. W., Didonato, J. A., Lusis, A. J., &amp; Hazen, S. L. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472(7341), 57&#x2013;63. https://doi.org/10.1038/nature09922</Citation></Reference><Reference><Citation>Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.&#x2010;Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., Sinha, R., Gilroy, E., Gupta, K., Baldassano, R., Nessel, L., Li, H., Bushman, F. D., &amp; Lewis, J. D. (2011). Linking long&#x2010;term dietary patterns with gut microbial enterotypes. Science, 334(6052), 105&#x2013;108. https://doi.org/10.1126/science.1208344</Citation></Reference><Reference><Citation>Yan, R., Murphy, M., Genoni, A., Marlow, E., Dunican, I. C., Lo, J., Andrew, L., Devine, A., &amp; Christophersen, C. T. (2020). Does fibre&#x2010;fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep, and mental health? A double&#x2010;blinded, randomised controlled trial. BMJ Open Gastroenterology, 7(1), e000448. https://doi.org/10.1136/bmjgast&#x2010;2020&#x2010;000448</Citation></Reference><Reference><Citation>Yang, B., Li, C., &amp; Zhu, H. (2018). Low FODMAP diet for the treatment of diarrhea type irritable bowel syndrome analysis. Modern Biomedical Progress, 17(22), 4298&#x2013;4302 + 4400. https://doi.org/10.13241/j.cnki.pmb.2018.22.022</Citation></Reference><Reference><Citation>Zhao, K., Wang, X., &amp; Wang, J. (2022). Effects of low FODMAP diet on nutritional status, inflammatory cytokine levels and intestinal flora in children with ulcerative colitis. Theory and practice of medicine, 35(21), 3746&#x2013;3747 + 3764.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>